Pharmacology, Toxicology and Pharmaceutical Science
Drug Metabolism
100%
7 Ethoxycoumarin
64%
Umbelliferone
55%
Ileum
33%
Quinidine
32%
CYP3A4
26%
Carbene
26%
P-Glycoprotein
26%
Drug-Drug Interaction
22%
Lidocaine
21%
CYP3A
21%
Adenosine Triphosphate
20%
Haplorhini
19%
Methyltestosterone
19%
Jejunum
18%
Rhodamine 123
17%
Malignant Neoplasm
17%
Inflammation
17%
Beta-Naphthoflavone
16%
Ketoconazole
15%
Free Fraction
13%
Warfarin
13%
Ischemia
13%
Bile Acid
13%
Methylcholanthrene
13%
Lipopolysaccharide
13%
Protein Binding
13%
Macaca fascicularis
13%
Lung Fibrosis
13%
Nylon Fiber
13%
Osteoprotegerin
13%
Inducible Nitric Oxide Synthase
13%
Cytochrome P450
13%
Nanoparticle
13%
Human Serum Albumin
13%
Enzyme Induction
13%
Cannabinoid 1 Receptor Antagonist
13%
Villin
13%
Anticarcinogen
13%
Verapamil
12%
Bioavailability
10%
IC50
10%
Valspodar
9%
Testosterone Derivative
9%
Alkaline Phosphatase
9%
Sulfate
9%
Glucuronide
9%
Drug Development
8%
Drug Toxicity
8%
Guanine Quadruplex
8%
Medicine and Dentistry
Liver Slice
75%
Drug Metabolism
48%
Intestine
35%
Hepatocyte
35%
Ischemia
26%
In Vitro
23%
Ex Vivo
22%
Tissue Slice
17%
Incubation
17%
7 Ethoxycoumarin
17%
Extracellular Matrix
16%
Cryopreservation
16%
Metabolite
13%
Injury
13%
Drug Toxicity
13%
Lipopolysaccharide
13%
Serositis
13%
Adipose Tissue
13%
Inducible Nitric Oxide Synthase
13%
Pulmonary Fibrosis
13%
Idiopathic Pulmonary Fibrosis
13%
Viaspan
13%
Treatment Response
13%
Ussing Chamber
13%
Stromal Cell
13%
Osteoprotegerin
13%
Drug Uptake
13%
Cytochrome P450
13%
Povidone
13%
Liver Cell
13%
Kidney Slice
13%
Cryoprotectant
13%
Adenosine Triphosphate
12%
Umbelliferone
11%
Biotransformation
11%
Lidocaine
10%
Metabolic Rate
10%
Preservation Solution
9%
Small Intestine
9%
Lung Slice
7%
Fibrosis
7%
Xenobiotic Agent
6%
Agarose
6%
Interleukin-1
6%
Tumor Necrosis Factor
6%
Atrolactic Acid
6%
Nitric Oxide
6%
Endothelial Cell
6%
Cardiopulmonary Resuscitation
5%
Liver Tissue
5%
Keyphrases
Precision-cut Intestinal Slices
65%
Ex Vivo Studies
39%
Apical Sodium-dependent Bile Acid Transporter
26%
P-glycoprotein (P-gp)
16%
Ex Vivo Model
16%
Rat Intestine
15%
P-glycoprotein Inhibitor
15%
Human Intestine
14%
Human Lung
14%
Induction Studies
13%
Cannabinoid Receptor 1 Antagonist
13%
Nanoparticle Formulation
13%
Reoxygenation Injury
13%
Luminal Preservation
13%
Ischemia-reoxygenation
13%
Human Liver
13%
Human Liver Slices
13%
Human Kidney
13%
In Vitro Test System
13%
Drug-metabolizing Activity
13%
Clearance Prediction
13%
Small Colon
13%
Metabolic Clearance
13%
Whole-body
13%
Cold Ischemia
13%
Ussing Chamber
13%
Warm Ischemia
13%
Drug Interactions
13%
Cytochrome P450 3A (CYP3A)
13%
Anticancer
13%
Bile Acids
13%
N-heterocyclic Carbene Complexes
13%
Acid Accumulation
13%
P-gp Activity
13%
P-glycoprotein Activity
13%
Lung Fibrosis
13%
Treatment Response
13%
Antifibrotic
13%
Early Markers
13%
Osteoprotegerin
13%
Fibrotic Process
13%
Ileum
11%
Drug Toxicity
10%
Quinidine
10%
University of Wisconsin Solution
10%
Cryopreserved
9%
Biopharmaceutics Classification System
8%
Kidney
8%
Human Tissue
8%
Cancer Cells
8%